| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/01.STR.30.5.981 |
| P698 | PubMed publication ID | 10229731 |
| P2093 | author name string | K R Lees | |
| K W Muir | |||
| I B Squire | |||
| C J Weir | |||
| W Alwan | |||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 981-985 | |
| P577 | publication date | 1999-05-01 | |
| P1433 | published in | Stroke Journal | Q7624282 |
| P1476 | title | C-reactive protein and outcome after ischemic stroke | |
| P478 | volume | 30 |
| Q35999554 | A Rich-Club Organization in Brain Ischemia Protein Interaction Network |
| Q57518101 | Acute stroke treatment using the Penumbra endovascular mechanical thrombolysis device: a single-centre experience |
| Q33436029 | Admission C-reactive protein after acute ischemic stroke is associated with stroke severity and mortality: the 'Bergen stroke study'. |
| Q39793210 | Antihypertensive drugs and inflammation in acute ischemic stroke as a predictor factor of future cardiovascular mortality |
| Q46643255 | Antioxidant supplementation enhances antioxidant capacity and mitigates oxidative damage following acute ischaemic stroke |
| Q46976052 | Antioxidant supplementation with or without B-group vitamins after acute ischemic stroke: a randomized controlled trial |
| Q36576596 | Association of clinical and aetiologic subtype of acute ischaemic stroke with inflammation, oxidative stress and vascular function: a cross-sectional observational study |
| Q36331024 | Basic mechanisms in intracranial large-artery atherosclerosis: advances and challenges. |
| Q36511707 | Biomarkers and functional outcomes from ischaemic cerebral events in women: a prospective cohort study |
| Q82623079 | C-Reactive Protein Levels in the First Three Hours After Acute Cerebral Infarction |
| Q28200344 | C-reactive protein (CRP)-lowering agents |
| Q48762513 | C-reactive protein after stroke in arterial hypertension |
| Q82037224 | C-reactive protein and aetiological subtypes of cerebral infarction |
| Q35562701 | C-reactive protein and cardiovascular disease: new insights from an old molecule |
| Q38162367 | C-reactive protein and hypertension |
| Q48805905 | C-reactive protein and nitric oxide levels in ischemic stroke and its subtypes: correlation with clinical outcome |
| Q33966178 | C-reactive protein as a prognostic marker after lacunar stroke: levels of inflammatory markers in the treatment of stroke study |
| Q52006849 | C-reactive protein elevation independently influences the procedural success of percutaneous balloon mitral valve commissurotomy. |
| Q64253243 | C-reactive protein for predicting all-cause mortality in patients with acute ischemic stroke: a meta-analysis |
| Q37428732 | C-reactive protein in the very early phase of acute ischemic stroke: association with poor outcome and death |
| Q84847773 | C-reactive protein is associated with the progression of acute embolic stroke in rabbit model |
| Q43889914 | C-reactive protein predicts death in patients with previous premature myocardial infarction--a 10 year follow-up study |
| Q40262287 | C-reactive protein predicts further ischemic events in transient ischemic attack patients. |
| Q60589757 | CRP Gene (1059G>C) Polymorphism and Its Plasma Levels in Ischemic Stroke and Hemorrhagic Stroke in a South Indian Population |
| Q28195775 | Changes in platelet P-selectin and in plasma C-reactive protein in acute atherosclerotic ischemic stroke treated with a loading dose of clopidogrel |
| Q39098660 | Chronic Stress and C-Reactive Protein in Mothers During the First Postpartum Year |
| Q49093865 | Circulating beta amyloid protein is elevated in patients with acute ischemic stroke |
| Q64106553 | Clinical characteristics and risk score for poor clinical outcome of acute ischemic stroke patients treated with intravenous thrombolysis therapy |
| Q44002474 | Combination of high-sensitivity C-reactive protein and homocysteine predicts the short-term outcomes of Chinese patients with acute ischemic stroke |
| Q35777054 | Comparison of acute versus convalescent stage high-sensitivity C-Reactive protein level in predicting clinical outcome after acute ischemic stroke and impact of erythropoietin |
| Q35503036 | Correlation between Serum D-Dimer Level and Volume in Acute Ischemic Stroke |
| Q48730877 | Early inflammatory response in ischemic stroke. |
| Q44523947 | Early neurological outcomes according to CHADS2 score in stroke patients with non-valvular atrial fibrillation |
| Q38333277 | Effect of C-reactive protein on gene expression in vascular endothelial cells |
| Q37995534 | Eicosanoids and their drugs in cardiovascular diseases: focus on atherosclerosis and stroke |
| Q37252186 | Elevated homocysteine and C-reactive protein levels independently predict worsening prognosis after stroke in Chinese patients |
| Q37997374 | Evolving role of biomarkers in acute cerebrovascular disease |
| Q34257104 | Gender, obesity and repeated elevation of C-reactive protein: data from the CARDIA cohort |
| Q35746446 | Generation of C-reactive protein and complement components in atherosclerotic plaques |
| Q37311787 | High sensitivity C-reactive protein levels in Acute Ischemic Stroke and subtypes: A study from a tertiary care center |
| Q48152110 | High-sensitivity C-reactive protein in high-grade carotid stenosis: risk marker for unstable carotid plaque |
| Q48597578 | High-sensitivity C-reactive protein is a strong risk factor for death after acute ischemic stroke among Chinese |
| Q39837396 | High-sensitivity CRP is correlated with neurologic symptoms and plaque instability in patients with severe stenosis of the carotid bifurcation |
| Q48276541 | Human C-reactive protein enhances vulnerability of immature rats to hypoxic-ischemic brain damage: a preliminary study |
| Q47400800 | Human C-reactive protein increases cerebral infarct size after middle cerebral artery occlusion in adult rats |
| Q49124233 | Human neurons generate C-reactive protein and amyloid P: upregulation in Alzheimer's disease |
| Q48899503 | IL-6: an early marker for outcome in acute ischemic stroke |
| Q49058047 | Improved neuronal survival of focal ischemia after delipid extracorporeal lipoprotein treatment in hyperlipidemic rabbits |
| Q43265286 | Increase in activity of neutrophils and proinflammatory mediators in rats following acute and prolonged focal cerebral ischemia and reperfusion. |
| Q28194382 | Inflammation and infection in clinical stroke |
| Q37923226 | Inflammation as a marker for the prediction of internal carotid artery restenosis following eversion endarterectomy--evidence from clinical studies |
| Q37267691 | Inflammation as a predictor for delayed cerebral ischemia after aneurysmal subarachnoid haemorrhage |
| Q37035033 | Inflammation in acute ischemic stroke and its relevance to stroke critical care. |
| Q52149539 | Inflammatory and metabolic markers and short-time outcome in patients with acute ischemic stroke in relation to TOAST subtypes. |
| Q35577700 | Innate Immunity, Local Inflammation, and Degenerative Disease |
| Q37257702 | Is there a correlation between hs-CRP levels and functional outcome of Ischemic Stroke? |
| Q37269843 | Laboratory studies in the investigation of stroke. |
| Q33260505 | Levels of acute phase proteins remain stable after ischemic stroke |
| Q28183244 | Link between platelet activity and outcomes after an ischemic stroke |
| Q35022588 | Local neuroinflammation and the progression of Alzheimer's disease |
| Q44736902 | Low serum n-3 polyunsaturated fatty acid/n-6 polyunsaturated fatty acid ratio predicts neurological deterioration in Japanese patients with acute ischemic stroke |
| Q35187308 | Multiple biomarker models for improved risk estimation of specific cardiovascular diseases related to metabolic syndrome: a cross-sectional study. |
| Q33533448 | Neuroimaging in acute ischaemic stroke: insights into unanswered questions of pathophysiology |
| Q34107356 | Novel risk factors for stroke: homocysteine, inflammation, and infection |
| Q48699033 | Nucleosomes in serum of patients with early cerebral stroke |
| Q24794415 | Peak plasma interleukin-6 and other peripheral markers of inflammation in the first week of ischaemic stroke correlate with brain infarct volume, stroke severity and long-term outcome |
| Q36039591 | Plasma C-Reactive Protein and Clinical Outcomes after Acute Ischemic Stroke: A Prospective Observational Study. |
| Q51464560 | Plasma concentrations of C-reactive protein and total homocysteine in relation to the severity and risk factors for cerebrovascular disease. |
| Q38644674 | Point-of-Care-Testing in Acute Stroke Management: An Unmet Need Ripe for Technological Harvest. |
| Q35148377 | Post-stroke inflammatory response: effects of stroke evolution and outcome |
| Q46731364 | Prediction of progressive motor deficits in patients with deep subcortical infarction. |
| Q43439066 | Predictive ability of C-reactive protein for early mortality after ischemic stroke: comparison with NIHSS score |
| Q36607347 | Predictors of early mortality in patients with ischemic stroke |
| Q33887006 | Predictors of stroke outcome |
| Q48332769 | Prognostic Value of Serum D-Dimer in Noncardioembolic Ischemic Stroke |
| Q54974777 | Prognostic value of C-reactive protein levels in patients with bone neoplasms: A meta-analysis. |
| Q81289043 | Prognostic value of admission C-reactive protein in stroke patients undergoing iv thrombolysis |
| Q44606853 | Relationship between levels of serum C-reactive protein, leucocyte count and carotid plaque in patients with ischemic stroke |
| Q52684105 | Relationship between serum vitamin D levels and inflammatory markers in acute stroke patients. |
| Q35111792 | Relevance of novel inflammatory markers in stroke-induced immunosuppression |
| Q55515874 | Risk factors for complications and mortality of percutaneous endoscopic gastrostomy insertion. |
| Q37959060 | Role of C-reactive protein in cerebrovascular disease: a critical review |
| Q57178507 | Role of Leptin in Acute Ischemic Stroke |
| Q44792514 | Routine serum C-reactive protein and stroke outcome after intravenous thrombolysis. |
| Q48310883 | Serial measurements of plasma homocysteine levels in early and late phases of ischemic stroke |
| Q36501673 | Serum C-reactive protein in dairy herds. |
| Q90187342 | Serum immunoglobulin G antibody titer to Fusobacterium nucleatum is associated with unfavorable outcome after stroke |
| Q92495744 | Similar thrombolysis outcomes in acute stroke patients with and without atrial fibrillation if pre-stroke CHA2DS2-VASc score is low: A retrospective study |
| Q36263096 | Study of genetic, metabolic and inflammatory risk factors in patients of acute ischemic stroke |
| Q47346589 | Systemic complement activation following human acute ischaemic stroke |
| Q38417525 | Systemic inflammation as a therapeutic target in acute ischemic stroke |
| Q44264411 | Systemic inflammatory stimulus potentiates the acute phase and CXC chemokine responses to experimental stroke and exacerbates brain damage via interleukin-1- and neutrophil-dependent mechanisms |
| Q34321555 | Systemic markers of inflammation are independently associated with S100B concentration: results of an observational study in subjects with acute ischaemic stroke |
| Q36559288 | The etiology of poststroke depression: a review of the literature and a new hypothesis involving inflammatory cytokines. |
| Q37433907 | The relationship between anemia and recurrence of ischemic stroke in patients with Trousseau's syndrome: A retrospective cross-sectional study. |
| Q57127143 | The relationship between oxidized low-density lipoprotein and related ratio and acute cerebral infarction |
| Q35843992 | The serum high-sensitive C reactive protein and homocysteine levels to evaluate the prognosis of acute ischemic stroke |
| Q28344629 | Tumor necrosis factor receptor levels are associated with carotid atherosclerosis |
| Q35109940 | Update on the Serum Biomarkers and Genetic Factors Associated with Safety and Efficacy of rt-PA Treatment in Acute Stroke Patients. |
| Q48395352 | Vitamin D deficiency is associated with acute ischemic stroke, C-reactive protein, and short-term outcome |
| Q74552962 | [C-reactive protein as a coronary risk factor] |
Search more.